Emerging human data, including small pilot studies showing good tolerability (e.g., intravenous infusions up to 20 mg with no adverse effects) and subjective improvements in conditions like chronic knee pain, further support its promise
10.1016/j.jpba.2021.114040 14 FrudeE.McKayF
If you start to feel symptoms returning before your next scheduled shot, its a sign to discuss this with your GP, as your programme might need adjusting
For the published literature on combined research protocols, see our BPC-157 + TB-500 stack research guide
A smooth, red, or sore tongue (glossitis) and pale or slightly yellowed skin
Fewer cells activating this final step of apoptosis means a larger proportion of the DPC population survives